Scandinavian Simvastatin Survival Study

Channel:
Subscribers:
9,560
Published on ● Video Link: https://www.youtube.com/watch?v=3gsx_N971n4



Duration: 4:54
33 views
1


The Scandinavian Simvastatin Survival Study (also known as the 4S study), was a multicentre, randomized, double-blind, placebo-controlled clinical trial, which provided the initial data that supported the use of the cholesterol-lowering drug, simvastatin, in people with a moderately raised cholesterol and coronary heart disease (CHD); that is people who had previously had a heart attack or angina. The study was sponsored by the pharmaceutical company Merck and enrolled 4,444 people from 94 centres in Scandinavia.Before the 4S study, it was not proven that lowering cholesterol could prolong life in people who had CHD. The study concluded that secondary prevention with simvastatin in a high risk group with CHD reduced overall mortality by 30%. Published in The Lancet in 1994, it is considered a "landmark paper".

Source: https://en.wikipedia.org/wiki/Scandinavian_Simvastatin_Survival_Study
Created with WikipediaReaderReborn (c) WikipediaReader




Other Videos By WikiReader


2021-09-16Irina Liuliakova
2021-09-16Critical Resistance
2021-09-16Automobile Alley (Oklahoma City, Oklahoma)
2021-09-16Wajihullah
2021-09-16Sachin Tanwar
2021-09-16Calopteryx hyalina
2021-09-16West Tisted
2021-09-16Varavis
2021-09-16Yuxin station
2021-09-16Gu Li (Han dynasty)
2021-09-16Scandinavian Simvastatin Survival Study
2021-09-16Bugil High School
2021-09-16Albert Kiplagat Matebor
2021-09-16Cornelius Nary
2021-09-16List of Canadian plants by family P–Q
2021-09-16DeAtley Island
2021-09-16HMS Pelorus (1896)
2021-09-16John Lomakoski
2021-09-16Ficus katendei
2021-09-16Kosakowo, Greater Poland Voivodeship
2021-09-16Bolshoy Utyash



Tags:
Angina
Cancer
Cerebrovascularevents
Cholesterol
Clinicaltrial
Coronaryheartdisease
Doiidentifier
ElsevierHealthSciences